Engy Tarek Elkoury

Dr. Engy Tarek Elkoury

orcid

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2025 in Brain Sciences
Verified
Journal Article
Open access
PDF file
EEEngy Tarek Elkoury
Engy Tarek Elkoury
AYAsmaa Yehia
Asmaa Yehia
ECElisabeth C. Caparelli
Elisabeth C. Caparelli
YGYonas E. Geda
Yonas E. Geda
DODakota Ortega
Dakota Ortega
OAOsama Ali Abulseoud
Osama Ali Abulseoud
Background: The potential long-term effects of Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV-2) infection on the brain structure have not yet been fully elucidated. Even though existing studies have reported structural changes in the post-COVID-19 period, the results remain highly inconsistent and controversial. As such, identifying an imaging biomarker for post-COVID brains is still under investigation. This review aims to comprehensively summarize the structural MRI (sMRI) studies that focus on volumetric brain changes at least two weeks following COVID-19 infection. Methods: A systematic literature search was conducted on PubMed, SCOPUS, Web of Science, EMBASE, and Google Scholar up to 9 September 2025. Studies that utilized sMRI to assess volumetric brain changes post-COVID at greater than two weeks following infection were included. Exclusion criteria encompassed research involving pediatric or adolescent populations and imaging modalities other than sMRI. Preprints, reviews, case reports, case series and post-mortem studies were also excluded. Results: Forty-one studies satisfied the inclusion criteria and consisted of 2895 patients and 1729 healthy controls. Despite the wide variability in image acquisition protocols, data processing methods, and comorbidities between studies, multiple studies reported statistically significant volumetric reductions in the hippocampus, amygdala, thalamus, basal ganglia, nucleus accumbens and the cerebellum months to years after infection, especially in older hospitalized patients with severe COVID-19. Conclusions: The emerging literature reports long-term volume changes across various brain regions in individuals previously infected with COVID-19; however, the evidence is inconsistent. Specific imaging biomarkers following exposure to SARS-CoV-2 infection and the underlying mechanisms of these changes are yet to be identified. Future studies with harmonized imaging protocols, longitudinal designs, and integrated biomarker and clinical data are needed to define robust biomarkers and elucidate the pathophysiology of these findings.

16 September 2026 in Langenbeck's Archives of Surgery
Verified
Journal Article
Open access
PDF file
Munder LateireshMunder Lateiresh
Munder Lateiresh
MEMohamed Elshiekh
Mohamed Elshiekh
NSNooreddin Saifi
Nooreddin Saifi
EGEwen Griffiths
Ewen Griffiths
SKSivesh Kamarajah
Sivesh Kamarajah
MEMuhammed Elhadi
Muhammed Elhadi
Background Postoperative nutritional support via a feeding jejunostomy (FJ) is vital for patients undergoing upper gastrointestinal surgery. This study evaluates the comparative safety and efficacy of laparoscopic feeding jejunostomy (LFJ) versus open feeding jejunostomy (OFJ). Methods Systematic review and meta-analysis of RCTs and comparative cohort studies comparing LFJ and OFJ, identified from major databases up to May 5, 2026. Primary outcomes: operative time and early mortality. Secondary outcomes: hospital stay, minor/major complications, time to enteral feeding, and day 1 pain scores. Random-effects models estimated RRs, MDs, or SMDs. Robustness was examined with leave-one-out sensitivity analyses; Galbraith plots were used to explore between-study heterogeneity rather than to test robustness. Meta-regression analyzed age and BMI as covariates. The certainty of evidence was appraised using the GRADE framework. Results Fifteen studies (n = 2,300; 1,290 LFJ, 1,010 OFJ) were included. LFJ significantly reduced minor postoperative complications (RR = 0.47, 95% CI: 0.32–0.67; I² = 0%), shortened hospital stay (MD = -1.09 days, 95% CI: -1.42 to -0.75; I² = 60.8%), accelerated enteral feeding (MD = -0.24 days, 95% CI: -0.34 to -0.13; I² = 0%), and lowered day 1 pain scores (SMD = -0.56, 95% CI: -0.87 to -0.24; I² = 0%). No significant differences were found in early mortality or major complications. Operative time showed high heterogeneity (I² = 98%), rendering evidence inconclusive. Sensitivity analyses indicated that some pooled estimates were sensitive to the exclusion of individual studies. Conclusions In this predominantly non-randomized evidence base, LFJ was associated with fewer minor complications, shorter hospital stay, and earlier enteral feeding, with no clear difference in early mortality or major complications. Because most data came from retrospective cohorts subject to confounding by indication, and the certainty of evidence ranged from very low to moderate across outcomes, these associations should be interpreted with caution and regarded as supportive rather than confirmatory. Nevertheless, further high-quality randomized controlled trials are warranted to strengthen the evidence base and better define the optimal surgical approach across different patient populations.

6 August 2026 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
Munder LateireshMunder Lateiresh
Munder Lateiresh
AQAyham Qatza
Ayham Qatza
EEEngy Tarek Elkoury
Engy Tarek Elkoury
TETareq H. F. Elwafae
Tareq H. F. Elwafae
MEMuhammed Elhadi
Muhammed Elhadi

9 June 2026 in BMC Anesthesiology
Verified
Journal Article
Open access
MAMohamed Yaseen Alfeetouri
Mohamed Yaseen Alfeetouri
Munder LateireshMunder Lateiresh
Munder Lateiresh
AQAyham Qatza
Ayham Qatza
EEEngy Tarek Elkoury
Engy Tarek Elkoury
NBNuran Arif Benfaid
Nuran Arif Benfaid
MEMuhammed Elhadi
Muhammed Elhadi
Hypoxemia is the most common adverse event during propofol-based procedural sedation for gastroscopy. Conventional nasal cannula oxygenation provides low flow rates, permitting room air entrainment and often proving insufficient. Nasal mask oxygenation delivers higher inspired oxygen concentrations, potentially enhancing respiratory safety during sedation. This study compared the efficacy and safety of nasal mask versus nasal cannula oxygen delivery during propofol-based procedural sedation for gastroscopy. Electronic databases/registries were systematically searched from inception to January 24, 2026, for randomized controlled trials (RCTs). Inclusion criteria encompassed adult patients undergoing propofol-based sedation for gastroscopy. The primary outcome was the incidence of hypoxemia. Secondary outcomes included severe hypoxemia, minimum oxygen saturation (SpO₂), need for airway or oxygenation interventions, procedure-related adverse events, and postoperative nausea and vomiting (PONV). Random-effects meta-analyses were performed using risk ratios (RRs) or mean differences (MDs) with 95% confidence intervals (CIs). Trial sequential analysis (TSA) assessed the sufficiency of the evidence. Risk of bias was evaluated using RoB 2, and certainty of evidence using GRADE. Five RCTs enrolled 1,267 patients, of whom 1,252 (98.8%) were included in the quantitative synthesis. Nasal mask oxygenation significantly reduced hypoxemia (RR 0.40, 95% CI 0.28 to 0.58, p < 0.0001) and severe hypoxemia (RR 0.39, 95% CI 0.22 to 0.67, p = 0.0007) compared with nasal cannula. Nasal masks also decreased the need for jaw thrust (RR 0.40, 95% CI 0.31 to 0.52) and mask-assisted ventilation (RR 0.16, 95% CI 0.05 to 0.46), while elevating minimum SpO₂ (MD 3.78, 95% CI 1.39 to 6.16). No significant differences emerged in coughing, hiccups, or PONV. Nasal mask oxygenation is associated with greater respiratory safety compared with nasal cannula oxygenation during propofol-sedated gastroscopy. This advantage manifests as reduced incidence of hypoxemia and fewer airway-related interventions, alongside a comparable overall safety profile. CRD420261291468.